MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers

Neuroscience Letters

Volumn 508, Issue 1, 2012, Pages 4-8

  Martinelli Boneschi, Filippo ^a   Fenoglio, Chiara ^b   Brambilla, Paola ^a   Sorosina, Melissa ^a   Giacalone, Giacomo ^a   Esposito, Federica ^a   Serpente, Maria ^b   Cantoni, Claudia ^b   Ridolfi, Elisa ^b   Rodegher, Mariaemma ^a   Moiola, Lucia ^a   Colombo, Bruno ^a   De Riz, Milena ^b   Martinelli, Vittorio ^a   Scarpini, Elio ^b   Comi, Giancarlo ^a   Galimberti, Daniela ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Gene expression; MicroRNA; Multiple sclerosis

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA;

ADULT; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN; MALE; MULTIPLE SCLEROSIS; NOTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; MULTIPLE SCLEROSIS; RNA, MESSENGER;

EID: 84855964851     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.11.006     Document Type: Note

References (29)

1. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
2. Baker B.J., Akhtar L.N., Benveniste E.N. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 2009, 30:392-400.
3. Balabanov R., Strand K., Goswami R., McMahon E., Begolka W., Miller S.D., Popko B. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27:2013-2024.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bomprezzi R., Ringner M., Kim S., Bittner M.L., Khan J., Chen Y., Elkahloun A., Yu A., Bielekova B., Meltzer P.S., Martin R., McFarland H.F., Trent J.M. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 2003, 12:2191-2199.
6. Brosnan C.F., John G.R. Revisiting Notch in remyelination of multiple sclerosis lesions. J. Clin. Invest. 2009, 119:10-13.
7. Burda P., Laslo P., Stopka T. The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis. Leukemia 2010, 24:1249-1257.
8. Chen X.M., Splinter P.L., O'Hara S.P., LaRusso N.F. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 2007, 282:28929-28938.
9. Cox M.B., Cairns M.J., Gandhi K.S., Carroll A.P., Moscovis S., Stewart G.J., Broadley S., Scott R.J., Booth D.R., Lechner-Scott J. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5:e12132.
10. De Santis G., Ferracin M., Biondani A., Caniatti L., Rosaria Tola M., Castellazzi M., Zagatti B., Battistini L., Borsellino G., Fainardi E., Gavioli R., Negrini M., Furlan R., Granieri E. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 2010, 226:165-171.
11. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252-1259.
12. + cell activation in patients with multiple sclerosis. Neurosci. Lett. 2011.
13. Furlan R., Rovaris M., Martinelli Boneschi F., Khademi M., Bergami A., Gironi M., Deleidi M., Agosta F., Franciotta D., Scarpini E., Uccelli A., Zaffaroni M., Kurne A., Comi G., Olsson T., Filippi M., Martino G. Immunological patterns identifying disease course and evolution in multiple sclerosis patients. J. Neuroimmunol. 2005, 165:192-200.
14. Gandhi K.S., McKay F.C., Cox M., Riveros C., Armstrong N., Heard R.N., Vucic S., Williams D.W., Stankovich J., Brown M., Danoy P., Stewart G.J., Broadley S., Moscato P., Lechner-Scott J., Scott R.J., Booth D.R. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Mol. Genet. 2010, 19:2134-2143.
15. Junker A., Krumbholz M., Eisele S., Mohan H., Augstein F., Bittner R., Lassmann H., Wekerle H., Hohlfeld R., Meinl E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009, 132:3342-3352.
16. Keller A., Leidinger P., Lange J., Borries A., Schroers H., Scheffler M., Lenhof H.P., Ruprecht K., Meese E. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009, 4:e7440.
17. Lindberg R.L., Hoffmann F., Mehling M., Kuhle J., Kappos L. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 2010, 40:888-898.
18. Lindsay M.A. microRNAs and the immune response. Trends Immunol. 2008, 29:343-351.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
21. Nakahara J., Kanekura K., Nawa M., Aiso S., Suzuki N. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J. Clin. Invest. 2009, 119:169-181.
22. Natoli G., Ghisletti S., Barozzi I. The genomic landscapes of inflammation. Genes Dev. 2011, 25:101-106.
23. Otaegui D., Baranzini S.E., Armananzas R., Calvo B., Munoz-Culla M., Khankhanian P., Inza I., Lozano J.A., Castillo-Trivino T., Asensio A., Olaskoaga J., Lopez de Munain A. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009, 4:e6309.
24. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann. Neurol. 2005, 58:840-846.
25. Ramanathan M., Weinstock-Guttman B., Nguyen L.T., Badgett D., Miller C., Patrick K., Brownscheidle C., Jacobs L. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 2001, 116:213-219.
26. Satoh J., Illes Z., Peterfalvi A., Tabunoki H., Rozsa C., Yamamura T. Aberrant transcriptional regulatory network in T cells of multiple sclerosis. Neurosci. Lett. 2007, 422:30-33.
27. Vandenbroeck K., Alvarez J., Swaminathan B., Alloza I., Matesanz F., Urcelay E., Comabella M., Alcina A., Fedetz M., Ortiz M.A., Izquierdo G., Fernandez O., Rodriguez-Ezpeleta N., Matute C., Caillier S., Arroyo R., Montalban X., Oksenberg J.R., Antiguedad A., Aransay A. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun. 2011.
28. Yu G., Luo H., Wu Y., Wu J. Ephrin B2 induces T cell costimulation. J. Immunol. 2003, 171:106-114.
29. Zhao J., Lu B., Xu H., Tong X., Wu G., Zhang X., Liang A., Cong W., Dai J., Wang H., Wu M., Guo Y. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology 2008, 48:265-275.